ES-SCLC: pembrolizumab KEYNOTE-604 data

Presented By
Dr Charles M. Rudin, Memorial Sloan Kettering Cancer Center, USA
Trial
Phase 3, KEYNOTE-604
Conference
ASCO 2020
Type
Peer-reviewed article

Immunotherapy in SCLC: trial data

Presented By
Dr Enriqueta Felip, Vall d’Hebron University Hospital, Spain
Trial
CA184-156, CheckMate-451, CASPIAN, Keynote-604, Checkmate 032
Conference
ELCC 2019
Type
Peer-reviewed article